News for Hologic, Inc. (H1OL34.SA)

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

We recently published a list of These 10 Stocks Exploded by Double Digits Today. In this article, we are going to take a look at where Hologic, Inc.

We recently published a list of These 10 Stocks Exploded by Double Digits Today. In this article, we are going to take a look at where Hologic, Inc. (NASDAQ:HOLX) stands against other best-performing stocks. Hologic ended a three-day losing streak on Tuesday, jumping 14.54 percent to finish at $62.17 apiece following news that it is […]

Hologic (HOLX) experiences a significant stock price surge following acquisition interest from TPG and Blackstone. Analysts offer a range of price targe

Trading for Hologic (HOLX) has recommenced after its recent suspension. Investors are regaining their focus on the company's performance, evaluating key perform

Hologic (HOLX) experienced a significant upswing, climbing 23% to reach $66.98 following the resumption of its trading activities. This notable increase highlig

Shares of Hologic (HOLX) soared by 7% and were temporarily halted after a report surfaced suggesting the company is the target of a take-private offer. This new

Zimmer Biomet Holdings, Inc. (ZBH) has announced the appointment of Kevin Thornal to the newly-created position of Group President, Global Businesses and the

PR NewswireWARSAW, Ind., May 27, 2025 WARSAW, Ind., May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technol

Zimmer Biomet (ZBH) appoints Kevin Thornal as Group President for Global Businesses and the Americas, effective July 1, 2025. Thornal brings over 20 yea

Summary Hologic Inc (HOLX) and its subsidiary, Biotheranostics, Inc., have announced new data showcasing the clinical impact of the Breast Cancer Index® (BCI®

Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating the significant clinical impact of the Breast Ca

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Morgan Stanley's analyst, Tejas Savant, has revised the price target for Hologic (HOLX), bringing it down to $65 from a previous $77. The shares maintain an Equ

Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate VP, IRSteve MacMillan -...

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Mizuho has revised its price target for Hologic (HOLX), reducing it from $83 to $75, while maintaining an Outperform rating on the stock. This adjustment comes

Bank of America has adjusted its price target for Hologic (HOLX), scaling it down to $70 from a previous $86, while maintaining a Neutral rating on the company'